Esperante BV’s most common sector for investment is life science (100%). The Firm’s most common investment types include secondary buyout (100%).
Join Mergr to view Esperante BV’s full profile and discover more small private equity firms just like it.
Esperante is a privately held investment company focussed on investing in therapeutics, in vitro diagnostics and selected medical device companies. The Firm will consider opportunities throughout Europe and North America. Esperante is based in Hoofddorp, The Netherlands with an additional office in Drayton, England.
Sectors of Interest: Life Science
Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture
Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Scandinavia
| Transaction Criteria | Min | Max |
|---|---|---|
| Target Revenue | - | - |
| Target EBITDA | - | - |
| Investment Size | - | - |
| Enterprise Value | - | - |
| Year | ≤ '15 | '16 | '17 | '18 | '19 | '20 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Company | Date | Value | Type |
|---|---|---|---|
| Altacor Ltd. | 2014-07-31 | - | Secondary Buyout |
| Cambridge, United Kingdom · www.altacor-pharma.com | |||
| View All >> | |||
| Sector | Current # | Value | All-time # | Value | |
|---|---|---|---|---|---|
| Life Science | 1 (100%) | - | 1 (100%) | - | |
| Total | 1 | - | 1 | - | |
| State/Country | Current # | Value | All-time # | Value | |
|---|---|---|---|---|---|
| United Kingdom | 1 (100%) | - | 1 (100%) | - | |
| Total | 1 | - | 1 | - | |
| Type | Current # | Value | All-time # | Value | |
|---|---|---|---|---|---|
| Secondary Buyout | 1 (100%) | - | 1 (100%) | - | |
| Total | 1 | - | 1 | - | |
| Deals | % | |
|---|---|---|
| Acquired from | ||
|
PE Firm(s)
|
2 | 100% |
